Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Other financing activities (2020 - 2021)

Historic Other financing activities for Arcutis Biotherapeutics (ARQT) over the last 2 years, with Q4 2021 value amounting to $1.6 million.

  • Arcutis Biotherapeutics' Other financing activities rose 44755.84% to $1.6 million in Q4 2021 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2022, which is 3359.8% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Other financing activities stood at $1.6 million for Q4 2021, which was up 44755.84% from -$471000.0 recorded in Q4 2020.
  • Arcutis Biotherapeutics' Other financing activities' 5-year high stood at $1.6 million during Q4 2021, with a 5-year trough of -$471000.0 in Q4 2020.